Sharps Technology and Coinbase Expand Relationship with Launch of Institutional-Grade Solana Validator GlobeNewswire January 12, 2026 NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (“STSS” or the “Company”) (NASDAQ: STSS), a medical device company implementing a Solana-based digital asset treasury strategy, today announced the expansion of its relationship with Coinbase Institutional, a […]

BioXcel Therapeutics Expands Leadership Team to Prepare for Launch of IGALMI(R) in the At-Home Setting GlobeNewswire January 12, 2026 Mark Pavao to Join BioXcel Therapeutics as Interim Chief Commercial Officer Mr. Pavao Brings Deep Experience in Neuroscience Sales and Marketing to Support Potential Launch of IGALMI(R) in At-Home Setting as Early as Year-End 2026 BioXcel

K Wave Media Leads Investment in “Once We Were Us,” Now the #1 Film at the Korean Box Office Top ranking at the Korean Box office with 1 million viewers in just 12 days GlobeNewswire January 12, 2026 NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) — K Wave Media Ltd. (Nasdaq: KWM), a global entertainment

Stallion Uranium Refines Coyote Target with Highly Conductive Anomalies from Ground EM Survey, Mobilizes Stone Island VTEM Survey GlobeNewswire January 12, 2026 VANCOUVER, British Columbia, Jan. 12, 2026 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion“) (TSX-V: STUD; OTCQB: STLNF; FSE: B76) is pleased to announce the completion of a ground-based Step-Wise Moving

Sable Announces Director Change GlobeNewswire January 12, 2026 VANCOUVER, British Columbia, Jan. 12, 2026 (GLOBE NEWSWIRE) — Sable Resources Ltd. (“Sable” or the “Company”) (TSXV:SAE | OTCQB:SBLRF) announces the change in OR Royalties' board nominee from Barry Quiroz to Guy Desharnais, effective immediately. Guy Desharnais is the current Vice President, Project Evaluation for OR Royalties.

Coppernico Defines 155 m of Continuous Copper Mineralization Averaging 0.54% at Sombrero's Nioc Target GlobeNewswire January 12, 2026 VANCOUVER, British Columbia, Jan. 12, 2026 (GLOBE NEWSWIRE) — Coppernico Metals Inc. (TSX: COPR, OTCQB: CPPMF, FSE: 9I3) (“Coppernico” or the “Company”), is pleased to announce results from recent geological mapping and channel sampling at Zone 1

Soleno Therapeutics Announces Select Preliminary Fourth Quarter and Full-Year 2025 Results GlobeNewswire January 12, 2026 REDWOOD CITY, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced select preliminary financial and operating results for the fourth quarter and

Skye Provides 2026 Corporate Outlook GlobeNewswire January 12, 2026 CBeyondTM Phase 2a 26-week extension data update and interim results expected Q1 2026. CBeyond Phase 2a Data Monitoring Committee (DMC) meeting on December 14, 2025, continued to demonstrate favorable safety profile. CBeyond Phase 2a topline results to 52 weeks including 13-week off-therapy follow-up period expected in

Relmada Therapeutics Provides Regulatory Update Confirming FDA Alignment on Registrational Studies Design for NDV-01 for Two Separate Indications GlobeNewswire January 12, 2026 FDA written feedback supports: – a single-arm, open-label registrational trial in 2nd-line refractory high-grade NMIBC with CIS – a randomized vs observation single trial in intermediate-risk NMIBC in the adjuvant setting Phase 3

NexGold Provides Summary of 2025 Activities and Key Priorities for 2026 GlobeNewswire January 12, 2026 TORONTO, Jan. 12, 2026 (GLOBE NEWSWIRE) — NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company“) is pleased to outline the Company's key milestones and achievements from the past year as it looks towards numerous significant catalysts for